Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05229016
Other study ID # AAAT8186
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 9, 2021
Est. completion date February 28, 2022

Study information

Verified date April 2023
Source Columbia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of the study is to assess which health-related questionnaire is the most accurate and reliable. The hypothesis is that some health-related questionnaires are more reliable than others.


Description:

The objective of the study is to test the reliability of patient reported outcome measures, and their robustness to patient-related factors. Patients will be randomly assigned to complete 1 of 6 patient reported outcome measures. Patients will either be asked to reflect on health-related experiences or not prior to completion of the questionnaire. Basic non-identifiable demographic information, and a brief medical questionnaire will follow completion of the patient reported outcome measure. Results from each individual patient reported outcome measure will be compared.


Recruitment information / eligibility

Status Completed
Enrollment 900
Est. completion date February 28, 2022
Est. primary completion date February 28, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 18 years of age and older, living in the US, fluent written and spoken English, able to consent Exclusion Criteria: Any criteria that does not meet the inclusion criteria

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Reflection on health-related experiences
This is a questionnaire that was designed to make the patient reflect on positive or negative health-related experiences.

Locations

Country Name City State
United States New York Presbyterian Hospital- Columbia University New York New York

Sponsors (3)

Lead Sponsor Collaborator
Columbia University Medical University of South Carolina, Northwestern University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary EQ-5D-5L score For the EQ-5D-5L, a scale of 1 to 5 with descriptors is used to score the domains of mobility, self-care, usual activities, pain/ discomfort and anxiety/ depression. A higher score represents a worse outcome. 15 minutes
Primary PROMIS Global health v1.2 score For the PROMIS Global Health v1.2, a score of 4 to 20 is calculated for the global physical health domain, and a score of 4 to 20 is calculated for the global mental health domain. A higher score represents a worse outcome. 15 minutes
Primary SF-36 score For the SF-36, a score of 0 to 100 is calculated for the domains of physical functioning, role limitations due to physical health, role limitations due to emotional problems, energy/ fatigue, emotional well-being, social functioning, pain, and general health. A higher score represents a more favorable outcome. 15 minutes
Primary Sinonasal Outcomes Test (SNOT)-22 score For the SNOT-22, a total score of 0 to 110 is calculated. The higher the score, the worse the outcome. 15 minutes
Primary Rhinosinusitis Disability Index (RSDI) score For the RSDI, a total score of 0 to 120 is calculated. The higher the score, the worse the outcome. 15 minutes
Primary mini-RQLQ score For the mini-RQLQ, a score 0 to 18 is calculated for the activities domain, 0 to 12 for the practical problems domain, 0 to 18 for the nose symptoms domain, 0 to 18 for the eye symptoms domain, and 0 to 18 for the other symptoms domain. A higher score represents a worse outcome. 15 minutes
Secondary Present Mood Visual Analogue Scale 10 cm visual analogue scale to rate mood. The scale is between 0 and 10. A higher score represents a better outcome 15 minutes
See also
  Status Clinical Trial Phase
Completed NCT06038435 - The Effect of Cognitive Orientation Approach on Daily Occupational Performance With Autism Spectrum Disorder N/A
Completed NCT05348603 - Electronic Health Record Strategies to Promote Diverse Participation in Research N/A
Completed NCT05502445 - The Nutritionist's Educational Intervention on the Protein Intake in Hospitalized Elderly People N/A
Completed NCT04153266 - Oral Epithelial Dysplasia Informational Needs Questionnaire
Terminated NCT00985907 - Doxil® + Melphalan + Velcade (DMV) in Relapsed/Refractory Multiple Myeloma Phase 1/Phase 2
Not yet recruiting NCT05537779 - Safety and Performance of Optivantage Multi-use When Injecting Contrast Media for Contrast Enhanced CT Examination
Completed NCT02989090 - Electronic Patient Notification of Remote ICD Data: Impact of Patient Engagement on Outcomes in the Merlin.Netâ„¢ N/A
Recruiting NCT05089799 - " Socially Pertinent Robot in Gerontological Healthcare "
Not yet recruiting NCT05603325 - Using Patient Feedback in Mental Health Services
Completed NCT02615769 - Effect on Attendance if Including Focused Information of Spirometry in Preventive Health Checks N/A
Completed NCT06138145 - Inclusion Appeal Videos and Intent to Register for Pediatric Clinical Trials N/A
Recruiting NCT02401919 - Basic Care Revisited_Communication for Patient Participation N/A
Completed NCT04288362 - Patient Activation Through Community Empowerment/Engagement for Diabetes Management (PACE-D) N/A
Completed NCT02714582 - Feasibility, Appropriateness, Meaningfulness and Effectiveness of Bedside Shift Reporting N/A
Recruiting NCT06337214 - TCM Therapy Program Impact on Breast Cancer Patients' Vital Energy N/A
Completed NCT04802512 - Turkish Version of Telehealth Usability Questionnaire (TUQ)
Recruiting NCT05787145 - ComCancer: Use of Let's Discuss Health Website by Patients With Prostate Cancer Undergoing Radiation Oncology Treatment N/A
Completed NCT03985163 - Patient Reported Outcomes for Opioid Use Disorder
Recruiting NCT04657783 - French National Cohort of People With Type 1 Diabetes
Recruiting NCT05779449 - Targeting the Gut Dysbiosis to Treat Inflammation-driven Synaptopathy in MS N/A